URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Lisa Beck

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentDermatology
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 697
Rochester NY 14642
Other Positions
TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentMedicine
DivisionMedicine - Allergy/Immunology and Rheumatology

 
 Awards And Honors
1992     Teaching Appreciation Award  | Johns Hopkins University
1992     Internal Medicine Teaching Award  | Francis Scott Key Medical Center
1994     Physician-Scientist Award  | National Institute of Health
1994     Research Award  | Dermatology Foundation
1997     Mentor for Howard Hughes Summer Fellowship Recipient  | Howard Hughes
2005     Mentor for Fujisawa AAAAI Research Grant Recipient  | Fujisawa
2006     Mentor for Astellas Skin Research Grant Recipient  | Astellas
2007     Mentor for NEASE Skin Research Grant Recipient  | NEASE
2007     Mentor for AAAAI Summer Research Grant Recipient  | AAAAI
2008     Dermatology Faculty Teaching Award  | University of Rochester Medical Center
 
 Overview
Dr. Beck's research interests are in three interrelated areas. First, we are interested in characterizing the epithelial tight junction defects at the molecular level in atopic dermatitis, the most common inflammatory skin disease in man. Numerous projects radiate from that central theme and include – 1) how do these defects differ in other inflammatory skin diseases such as chronic urticaria, psoriasis, CTCL, 2) what effects do various pharmacologic agents have on TJ function and structure, 3) can protease containing allergens or microbes affect TJ function and if so how. A second area of focus is evaluating the magnitude and character of the microbial responsiveness of keratinocytes (cutaneous epithelial cells) from atopic dermatitis subjects compared to nonatopic healthy controls. When differences are noted we are trying to determine the basis for these differences and believe this line of inquiry may explain AD subjects' susceptibility to colonization and infection with numerous bacteria, viruses and even yeast. Our third area has been to understand why there is such a paucity of tissue neutrophils in lesions from subjects with atopic dermatitis. These studies are not as advanced but suggest that there are phenotypic differences in AD neutrophils' responsiveness to the potent chemoattractant, IL-8 (CXCL8) compared to nonatopic controls.

 
 Selected Publications
List All   |   Timeline
  1. Rezaee F, Desando SA, Ivanov AI, Chapman TJ, Knowlden SA, Beck LA, Georas SN. Sustained protein kinase d activation mediates respiratory syncytial virus-induced airway barrier disruption. J Virol. 2013 Oct; 87(20):11088-95.
    View in: PubMed
  2. Mortensen LJ, Jatana S, Gelein R, De Benedetto A, De Mesy Bentley KL, Beck LA, Elder A, Delouise LA. Quantification of quantum dot murine skin penetration with UVR barrier impairment. Nanotoxicology. 2013 Dec; 7:1386-98.
    View in: PubMed
  3. Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol. 2013 Feb; 131(2):266-78.
    View in: PubMed
  4. Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, Gallo RL, Borkowski AW, Yamasaki K, Leung DY, Georas SN, De Benedetto A, Beck LA. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol. 2013 Apr; 133(4):988-98.
    View in: PubMed
  5. Denby KS, Beck LA. Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol. 2012 Aug; 12(4):421-6.
    View in: PubMed
  6. Bernhardt KA, Beck LA, Lamb JL, Kaufman KR, Amin S, Wuermser LA. Weight bearing through lower limbs in a standing frame with and without arm support and low-magnitude whole-body vibration in men and women with complete motor paraplegia. Am J Phys Med Rehabil. 2012 Apr; 91(4):300-8.
    View in: PubMed
  7. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol. 2012 Mar; 132(3 Pt 2):949-63.
    View in: PubMed
  8. Mantel A, Carpenter-Mendini AB, Vanbuskirk JB, De Benedetto A, Beck LA, Pentland AP. Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis. J Invest Dermatol. 2012 Apr; 132(4):1103-10.
    View in: PubMed
  9. Gao PS, Leung DY, Rafaels NM, Boguniewicz M, Hand T, Gao L, Hata TR, Schneider LC, Hanifin JM, Beaty TH, Beck LA, Weinberg A, Barnes KC. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol. 2012 Mar; 132(3 Pt 1):650-7.
    View in: PubMed
  10. Bundy KW, McGirt LY, Bankova LG, Wollenberg A, Beck LA, De Benedetto A. Mannan-binding lectin levels and activity are not altered in atopic dermatitis patients with a history of eczema herpeticum. Dermatol Res Pract. 2011; 2011:769890.
    View in: PubMed
  11. Rezaee F, Meednu N, Emo JA, Saatian B, Chapman TJ, Naydenov NG, De Benedetto A, Beck LA, Ivanov AI, Georas SN. Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells. J Allergy Clin Immunol. 2011 Dec; 128(6):1216-1224.e11.
    View in: PubMed
  12. Howell MD, Gao P, Kim BE, Lesley LJ, Streib JE, Taylor PA, Zaccaro DJ, Boguniewicz M, Beck LA, Hanifin JM, Schneider LC, Hata TR, Gallo RL, Kaplan MH, Barnes KC, Leung DY. The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections. J Allergy Clin Immunol. 2011 Nov; 128(5):1006-14.
    View in: PubMed
  13. De Benedetto A, Slifka MK, Rafaels NM, Kuo IH, Georas SN, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Johnson DC, Barnes KC, Leung DY, Beck LA. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol. 2011 Jul; 128(1):242-246.e5.
    View in: PubMed
  14. Zhang K, Tian Y, Yin L, Zhang M, Beck LA, Zhang B, Okunieff P, Zhang L, Vidyasagar S. Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):248-54.
    View in: PubMed
  15. Leung DY, Gao PS, Grigoryev DN, Rafaels NM, Streib JE, Howell MD, Taylor PA, Boguniewicz M, Canniff J, Armstrong B, Zaccaro DJ, Schneider LC, Hata TR, Hanifin JM, Beck LA, Weinberg A, Barnes KC. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-? response. J Allergy Clin Immunol. 2011 Apr; 127(4):965-73.e1-5.
    View in: PubMed
  16. Boyce JA, Assa'a A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition. 2011 Feb; 27(2):253-67.
    View in: PubMed
  17. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res. 2011 Jan; 31(1):61-75.
    View in: PubMed
  18. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol. 2011 Jan; 64(1):175-92.
    View in: PubMed
  19. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Novak N, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011 Mar; 127(3):773-86.e1-7.
    View in: PubMed
  20. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010 Dec; 126(6 Suppl):S1-58.
    View in: PubMed
  21. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol. 2010 Dec; 126(6):1105-18.
    View in: PubMed
  22. Lee FE, Georas SN, Beck LA. IL-17: important for host defense, autoimmunity, and allergy? J Invest Dermatol. 2010 Nov; 130(11):2540-2.
    View in: PubMed
  23. Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol. 2010 Jun; 125(6):1403-1407.e4.
    View in: PubMed
  24. Georas SN, Rezaee F, Lerner L, Beck L. Dangerous allergens: why some allergens are bad actors. Curr Allergy Asthma Rep. 2010 Mar; 10(2):92-8.
    View in: PubMed
  25. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2009 Sep; 124(3 Suppl 2):R7-R12.
    View in: PubMed
  26. Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Barnes KC, Leung DY. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. 2009 Sep; 124(3):507-13, 513.e1-7.
    View in: PubMed
  27. Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009 Aug; 124(2):260-9, 269.e1-7.
    View in: PubMed
  28. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol. 2009 Jan; 129(1):14-30.
    View in: PubMed
  29. Georas SN, Beck L. Dangerous allergens: innate immunity, dendritic cells and allergic asthma. Expert Rev Clin Immunol. 2008 Nov; 4(6):777-85.
    View in: PubMed
  30. Warner JA, McGirt LY, Beck LA. Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis. Br J Dermatol. 2009 Jan; 160(1):183-5.
    View in: PubMed
  31. Borregaard J, Skov L, Wang L, Ting N, Wang C, Beck LA, Sonne J, Clucas A. Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects. Contact Dermatitis. 2008 Oct; 59(4):212-9.
    View in: PubMed
  32. Ibrahim SF, Pryor J, Merritt RW, Scott G, Beck LA. Cutaneous myiasis arising in an eccrine adnexal neoplasm. Dermatol Online J. 2008; 14(6):6.
    View in: PubMed
  33. Beck LA, Einertson MJ, Winemiller MH, DePompolo RW, Hoppe KM, Sim FF. Functional outcomes and quality of life after tumor-related hemipelvectomy. Phys Ther. 2008 Aug; 88(8):916-27.
    View in: PubMed
  34. Cheville AL, Beck LA, Petersen TL, Marks RS, Gamble GL. The detection and treatment of cancer-related functional problems in an outpatient setting. Support Care Cancer. 2009 Jan; 17(1):61-7.
    View in: PubMed
  35. Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol. 2008 Apr; 100(4):291-7; quiz 297-9, 322.
    View in: PubMed
  36. Brodell LA, Beck LA. Differential diagnosis of chronic urticaria. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):181-8; quiz 188-90, 215.
    View in: PubMed
  37. De Benedetto A, Qualia CM, Baroody FM, Beck LA. Filaggrin expression in oral, nasal, and esophageal mucosa. J Invest Dermatol. 2008 Jun; 128(6):1594-7.
    View in: PubMed
  38. Conner E, Bochner BS, Brummet M, Beck LA. The effect of etanercept on the human cutaneous allergic response. J Allergy Clin Immunol. 2008 Jan; 121(1):258-60.
    View in: PubMed
  39. Delong LK, Culler SD, Saini SS, Beck LA, Chen SC. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. Arch Dermatol. 2008 Jan; 144(1):35-9.
    View in: PubMed
  40. Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol. 2008 Jan; 121(1):260-2.
    View in: PubMed
  41. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007 Jul; 120(1):150-5.
    View in: PubMed
  42. McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol. 2006 Oct; 142(10):1337-42.
    View in: PubMed
  43. Beck LA, Saini S. Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis. J Am Acad Dermatol. 2006 Sep; 55(3):540-1; author reply 541-2.
    View in: PubMed
  44. Beck LA, Tancowny B, Brummet ME, Asaki SY, Curry SL, Penno MB, Foster M, Bahl A, Stellato C. Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. J Immunol. 2006 Sep 1; 177(5):3344-54.
    View in: PubMed
  45. Conner ER, Beck LA. Emerging therapeutic options for atopic dermatitis: beyond TIMs. Curr Allergy Asthma Rep. 2006 Jul; 6(4):275-81.
    View in: PubMed
  46. Gounni Abdelilah S, Wellemans V, Agouli M, Guenounou M, Hamid Q, Beck LA, Lamkhioued B. Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines. Clin Immunol. 2006 Aug; 120(2):220-31.
    View in: PubMed
  47. McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol. 2006 Jul; 118(1):202-8.
    View in: PubMed
  48. Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J Allergy Clin Immunol. 2006 Jul; 118(1):70-7.
    View in: PubMed
  49. Esche C, Stellato C, Beck LA. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol. 2005 Oct; 125(4):615-28.
    View in: PubMed
  50. Beck LA. The efficacy and safety of tacrolimus ointment: a clinical review. J Am Acad Dermatol. 2005 Aug; 53(2 Suppl 2):S165-70.
    View in: PubMed
  51. Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S. Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. J Allergy Clin Immunol. 2004 Sep; 114(3):527-30.
    View in: PubMed
  52. Esche C, de Benedetto A, Beck LA. Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep. 2004 Jul; 4(4):276-84.
    View in: PubMed
  53. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol. 2004 Sep; 31(3):358-64.
    View in: PubMed
  54. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol. 2004 Jan; 113(1):115-9.
    View in: PubMed
  55. Beck LA. Cancer rehabilitation: does it make a difference? Rehabil Nurs. 2003 Mar-Apr; 28(2):42-7.
    View in: PubMed
  56. Eichenfield LF, Hanifin JM, Beck LA, Lemanske RF, Sampson HA, Weiss ST, Leung DY. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics. 2003 Mar; 111(3):608-16.
    View in: PubMed
  57. Georas SN, Beck LA, Stellato C. What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells. Am J Respir Cell Mol Biol. 2002 Apr; 26(4):384-7.
    View in: PubMed
  58. Stellato C, Brummet ME, Plitt JR, Shahabuddin S, Baroody FM, Liu MC, Ponath PD, Beck LA. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. J Immunol. 2001 Feb 1; 166(3):1457-61.
    View in: PubMed
  59. Beck LA, Scroggins LM. Optimizing health of individuals with tetraplegia. SCI Nurs. 2001; 18(4):181-6.
    View in: PubMed
  60. Seminario MC, Guo J, Bochner BS, Beck LA, Georas SN. Human eosinophils constitutively express nuclear factor of activated T cells p and c. J Allergy Clin Immunol. 2001 Jan; 107(1):143-52.
    View in: PubMed
  61. Cooper PJ, Beck LA, Espinel I, Deyampert NM, Hartnell A, Jose PJ, Paredes W, Guderian RH, Nutman TB. Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis. Clin Immunol. 2000 Apr; 95(1 Pt 1):51-61.
    View in: PubMed
  62. Lee SC, Brummet ME, Shahabuddin S, Woodworth TG, Georas SN, Leiferman KM, Gilman SC, Stellato C, Gladue RP, Schleimer RP, Beck LA. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J Immunol. 2000 Mar 15; 164(6):3392-401.
    View in: PubMed
  63. Chen R, Burke TF, Cumberland JE, Brummet M, Beck LA, Casolaro V, Georas SN. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter. J Immunol. 2000 Jan 15; 164(2):825-32.
    View in: PubMed
  64. Beck LA, Chase T, Le L, Evans D, Tolbert G. The personal side of technology. SCI Nurs. 2000; 17(3):130-2.
    View in: PubMed
  65. Beck LA, Harris MR, Basford J. Factors influencing functional outcome and discharge disposition after thoracic spinal cord injury. SCI Nurs. 1999 Dec; 16(4):127-32.
    View in: PubMed
  66. Stellato C, Matsukura S, Fal A, White J, Beck LA, Proud D, Schleimer RP. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol. 1999 Nov 15; 163(10):5624-32.
    View in: PubMed
  67. Matsumoto K, Appiah-Pippim J, Schleimer RP, Bickel CA, Beck LA, Bochner BS. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol. 1998 Jun; 18(6):860-6.
    View in: PubMed
  68. Beck LA. Morbid obesity and spinal cord injury: a case study. SCI Nurs. 1998 Mar; 15(1):3-5.
    View in: PubMed
  69. DeYampert NM, Beck LA. Eosinophilia and multiple erythematous indurated plaques. Idiopathic hypereosinophilic syndrome (IHS). Arch Dermatol. 1997 Dec; 133(12):1581, 1584.
    View in: PubMed
  70. Beck LA, Dalke S, Leiferman KM, Bickel CA, Hamilton R, Rosen H, Bochner BS, Schleimer RP. Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects. J Immunol. 1997 Sep 15; 159(6):2962-72.
    View in: PubMed
  71. Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res. 1997 Apr 15; 57(8):1537-46.
    View in: PubMed
  72. Beck LA, Lovlien CA, Twedell DM. Care of morbidly obese people with spinal cord injury. J Trauma Nurs. 1996 Oct-Dec; 3(4):98-107; quiz 108-9.
    View in: PubMed
  73. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, Baroody F, Bochner BS, Schleimer RP. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol. 1996 Oct; 98(4):766-80.
    View in: PubMed
  74. Schwiebert LM, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP, Schwiebert LA. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol. 1996 Jan; 97(1 Pt 2):143-52.
    View in: PubMed
  75. Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, Lichtenstein LM, Schleimer RP. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol. 1995 Jul 1; 155(1):410-8.
    View in: PubMed

Visualizations


Beck's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department